Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncertainty surrounding Trump’s tariffs.

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

Bristol-Myers Squibb $74 billion takeover of Celgene saw it shoot up the list of top 20 pharma companies by market cap into the top 10, according to a new analysis by GlobalData. BMS had the ...

Some of the most exciting new drugs are being discovered by mid-sized pharma and biotech companies ... GlobalData analysed a group of 35 mid-cap companies, most of which are based in the US ...

Below the Investing News Network profiles the top five small-cap pharma stocks on the ... using TradingView’s stock screener, and pharma companies with market caps between US$50 million and ...

Global Data has revealed that the Top 20 Global Biopharmaceutical Companies have witnessed a 6 % growth in market ...

Figure 1: Top 20 global biopharmaceutical companies, by market cap, as of 31 March 2025 Source: GlobalData, Pharma Intelligence Center; Stock Exchanges; Annual Reports. Vertex Pharmaceuticals ...